6.78%
16.94%
10.19%
-1.35%
6.99%
4.38%
89.69%
AI Spotlight on TMO
Company Description
Thermo Fisher Scientific Inc.provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products.Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research.
It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD.Thermo Fisher Scientific Inc.was founded in 1956 and is headquartered in Waltham, Massachusetts.
Market Data
| Last Price | 606.74 |
| Change Percentage | 6.78% |
| Open | 590.6 |
| Previous Close | 568.23 |
| Market Cap ( Millions) | 232078 |
| Volume | 3019284 |
| Year High | 627.88 |
| Year Low | 493.3 |
| M A 50 | 535.72 |
| M A 200 | 570.08 |
Financial Ratios
| FCF Yield | 3.35% |
| Dividend Yield | 0.26% |
| ROE | 13.24% |
| Debt / Equity | 63.12% |
| Net Debt / EBIDTA | 260.67% |
| Price To Book | 4.68 |
| Price Earnings Ratio | 36.58 |
| Price To FCF | 29.85 |
| Price To sales | 5.41 |
| EV / EBITDA | 24.79 |
News
- Jan -30 - Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates
- Jan -30 - Thermo Fisher Q4 Earnings and Revenues Top Estimates, Stock Up
- Jan -30 - Thermo Fisher (TMO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Jan -30 - Thermo Fisher Scientific Inc. (TMO) Q4 2024 Earnings Call Transcript
- Jan -30 - Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Top Estimates
- Jan -30 - Thermo Fisher beats quarterly estimates on strong demand for its tools and services
- Jan -30 - Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results
- Jan -24 - Is Thermo Fisher Stock Worth Holding on to in Your Portfolio?
- Jan -24 - Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase
- Jan -23 - Robust Analytical Instruments Segment Likely to Aid TMO's Q4 Earnings
- Jan -22 - Biologicals Is The Future In Thermo Fisher: Buy Rating
- Jan -15 - Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
- Jan -14 - Thermo Fisher Scientific Inc. (TMO) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
- Jan -14 - Macroeconomic Woes, Competition Weigh on TMO's Stock Performance
- Jan -10 - Thermo Fisher Scientific's Olink Platform Selected for World's Largest Human Proteome Study
- Jan -02 - Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025
- Dec -18 - Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific
- Dec -17 - Bioproduction Prospects to Drive TMO Shares Despite Macroeconomic Woes
- Dec -13 - Thermo Fisher: The Cycle Has Already Turned Around
- Dec -11 - TMO Institutional & Insider Stock Sell-Offs Upset Market: How to Play
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Laboratory Products and Biopharma Services
Expected Growth : 4.5 %
What the company do ?
Laboratory Products and Biopharma Services from Thermo Fisher Scientific Inc. provides life science research and bioproduction solutions, including instruments, reagents, and contract manufacturing services.
Why we expect these perspectives ?
Thermo Fisher Scientific Inc.'s Laboratory Products and Biopharma Services segment growth of 4.5% is driven by increasing demand for biologics and vaccines, expansion in emerging markets, and strategic acquisitions. Additionally, investments in research and development, and growing adoption of precision medicine and gene therapy contribute to the segment's growth.
Segment n°2 -> Life Sciences Solutions
Expected Growth : 4.8 %
What the company do ?
Life Sciences Solutions from Thermo Fisher Scientific Inc. provides innovative products and services for research, discovery, and diagnostics in biotechnology, pharmaceutical, and academic markets.
Why we expect these perspectives ?
Thermo Fisher Scientific Inc.'s Life Sciences Solutions segment growth of 4.8% is driven by increasing demand for biopharmaceuticals, vaccines, and gene therapies, as well as the need for advanced research and development tools. Additionally, the segment benefits from the company's strong presence in emerging markets and its ability to provide integrated solutions for customers.
Segment n°3 -> Analytical Instruments
Expected Growth : 4.2 %
What the company do ?
Analytical Instruments from Thermo Fisher Scientific Inc. provide innovative solutions for laboratory settings, enabling scientists to analyze and identify the chemical composition of substances.
Why we expect these perspectives ?
Thermo Fisher Scientific's Analytical Instruments segment growth of 4.2% is driven by increasing demand for biopharmaceutical research, expansion in emerging markets, and adoption of advanced technologies such as mass spectrometry and chromatography. Additionally, the segment benefits from the company's strategic acquisitions and investments in R&D, enhancing its product portfolio and customer offerings.
Segment n°4 -> Specialty Diagnostics
Expected Growth : 4.0 %
What the company do ?
Specialty Diagnostics from Thermo Fisher Scientific Inc. provides innovative diagnostic solutions, including molecular diagnostics, microbiology, and immunodiagnostics, to improve patient outcomes.
Why we expect these perspectives ?
Thermo Fisher Scientific Inc.'s Specialty Diagnostics segment growth is driven by increasing demand for molecular diagnostics, expansion in emerging markets, and strategic acquisitions. Additionally, the segment benefits from the company's strong brand recognition, innovative product offerings, and growing adoption of precision medicine. These factors contribute to a growth rate of 4.0%.
Segment n°5 -> Eliminations
Expected Growth : 0.0 %
What the company do ?
Eliminations from Thermo Fisher Scientific Inc. refer to the removal of redundant or overlapping businesses, resulting in a more streamlined and efficient organizational structure.
Why we expect these perspectives ?
Thermo Fisher Scientific Inc.'s eliminations segment shows 0.0% growth, driven by the absence of intercompany transactions and eliminations of revenue and expenses between subsidiaries, resulting in no net impact on the company's overall financial performance.
Thermo Fisher Scientific Inc. Products
| Product Range | What is it ? |
|---|---|
| Laboratory Instruments | Thermo Fisher Scientific offers a wide range of laboratory instruments, including spectrophotometers, chromatography systems, and microscopes, designed to support various scientific research and testing applications. |
| Life Science Reagents | Thermo Fisher Scientific provides a broad portfolio of life science reagents, including antibodies, proteins, and nucleic acid-based products, used in various biological research and diagnostic applications. |
| Biosciences | Thermo Fisher Scientific offers a range of biosciences products, including gene expression analysis, protein analysis, and cell culture media, used in various biological research and diagnostic applications. |
| Pharmaceutical Services | Thermo Fisher Scientific provides pharmaceutical services, including contract research, development, and manufacturing, to support the development and commercialization of pharmaceutical products. |
| Laboratory Consumables | Thermo Fisher Scientific offers a wide range of laboratory consumables, including pipette tips, microplates, and laboratory plastics, used in various scientific research and testing applications. |
| Bioproduction | Thermo Fisher Scientific provides bioproduction products and services, including cell culture media, bioreactors, and downstream processing, used in the development and manufacturing of biologics and vaccines. |
| Software and Informatics | Thermo Fisher Scientific offers a range of software and informatics solutions, including laboratory information management systems, electronic laboratory notebooks, and bioinformatics tools, used in various scientific research and testing applications. |
Thermo Fisher Scientific Inc.'s Porter Forces
Threat Of Substitutes
Thermo Fisher Scientific Inc. has a moderate threat of substitutes due to the presence of alternative products and services in the life sciences and biotechnology industries.
Bargaining Power Of Customers
Thermo Fisher Scientific Inc. has a low bargaining power of customers due to its strong brand reputation and diversified customer base.
Bargaining Power Of Suppliers
Thermo Fisher Scientific Inc. has a moderate bargaining power of suppliers due to its dependence on a few key suppliers for raw materials and components.
Threat Of New Entrants
Thermo Fisher Scientific Inc. has a low threat of new entrants due to the high barriers to entry in the life sciences and biotechnology industries, including significant capital requirements and regulatory hurdles.
Intensity Of Rivalry
Thermo Fisher Scientific Inc. operates in a highly competitive industry with several established players, leading to a high intensity of rivalry.
Strength
Capital Structure
| Value | |
|---|---|
| Debt Weight | 42.77% |
| Debt Cost | 4.12% |
| Equity Weight | 57.23% |
| Equity Cost | 7.91% |
| WACC | 6.29% |
| Leverage | 74.73% |
Thermo Fisher Scientific Inc. : Quality Control
Thermo Fisher Scientific Inc. passed 5 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| IQV | IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: … |
| MTD | Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and … |
| A | Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; … |
| IDXX | IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; … |
| DHR | Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Mettler-Toledo
A-Score
1-Year Total Return ->
🥈
Thermo Fisher
A-Score
1-Year Total Return ->
🥉
Danaher
A-Score
1-Year Total Return ->
4
Agilent Technologies
A-Score
1-Year Total Return ->
5
IQVIA
A-Score
1-Year Total Return ->
6
